Outcome of board meeting of Kilpest India subsidiary
Held on 22 November 2017
Kilpest India announced that the Board of its subsidiary, 3B BlackBio Biotech India has approved the preferential issue of up to 4 lakh warrants convertible into equity shares of Rs 10 each at a price of Rs 100 each to promoters and non promoter entities subject to approval of members.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content